Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 10/20 | 0.54 |
| ▸ | FNTB | P49356 | 10/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5733786 | 0.70 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL13186537 | 0.70 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL7707732 | 0.69 | FNTA (0.76) | FNTAFNTBPGGT1B | |
| SCHEMBL13573613 | 0.68 | FNTA (0.81) | FNTAFNTB | |
| SCHEMBL3436599 | 0.68 | FNTA (0.81) | FNTAFNTB | |
| SCHEMBL28532205 | 0.68 | IDO1 (0.50) | FNTAFNTBPGGT1B | |
| SCHEMBL6010160 | 0.68 | FNTA (0.78) | FNTAFNTB | |
| Hydrochloric Acid SCHEMBL6010264 | 0.68 | FNTA (0.78) | FNTAFNTB | |
| SCHEMBL3847890 | 0.67 | FNTA (0.76) | FNTAFNTB | |
| SCHEMBL5516120 | 0.67 | FNTA (0.72) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020091138-A1 | Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation | END DAVID WILLIAM (US) | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091138-A1 | Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation | MYLK, ACTN1, ALK | FNTA 4747/4885FNTB 4394/4885PGGT1B 2543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.